The Most Impactful Symptom of Endometriosis Questionnaire (MISE-Q): a cognitive interview study

Alice M Mitchell, Sara Attinger, Jane Chalmers, Steven J Kamper, Helena Frawley, Claudia Cheng, Martin Healey, Andrew W. Horne, Lucy Whitaker, Jason Abbott, Luk Rombauts, Stacey A. Missmer, Karin Jones, Anita Elias, Claudia Rutherford, Brian W Pulling, Sarah Lensen
Current medical research and opinion · 2026 · pp. 1–12 · doi:10.1080/03007995.2026.2730839 · PMID:42813251 · W7214981321
Qualitative OA: hybrid public-domain-us
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-10-06 ⓘ

This cognitive interview study evaluated the content validity of the MISE-Q, a new patient-reported outcome measure for endometriosis that captures the most impactful symptom through iterative feedback and revisions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: Endometriosis is a condition with symptoms that vary widely, often affecting daily activities and quality of life. A patient-centered approach to identifying and measuring the most important symptoms has been recommended in the core outcome set for endometriosis clinical trials, yet no such instrument currently exists. This study aimed to pilot-test a new patient-reported outcome measure, the "Most Impactful Symptom of Endometriosis Questionnaire" (MISE-Q), designed to address this gap. METHODS: The MISE-Q's content validity was evaluated through cognitive interviews using the Three-Step Test-Interview method. Participants with a surgical diagnosis of endometriosis were recruited and interviewed across five iterative rounds. RESULTS: Thirty-four interviews were conducted, revealing diverse symptom experiences. Most participants appreciated the person-centered nature of the instrument, though some found it difficult to choose a single "most impactful symptom" due to overlapping symptoms. A three-month recall period was supported to capture symptom fluctuation over time. Clinician and researcher feedback was incorporated to improve clarity, usability, and feasibility. The MISE-Q was revised, including changes to symptom wording, and the removal of two symptoms and the addition of one. A free-text option was included to capture additional symptoms due to the condition's heterogeneity. Participants praised the MISE-Q's brevity and clear language. CONCLUSION: The final instrument offers a comprehensive tool to measure the "most impactful symptom" of endometriosis. While it represents the most rigorously developed option available for this purpose, its use in clinical trials should be preceded by field testing to establish additional measurement properties and assess cultural relevance across populations.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

Source provenance

europepmc
last seen: 2026-10-11T09:27:45.537177+00:00
openalex
last seen: 2026-10-11T06:05:52.046646+00:00
pubmed
last seen: 2026-10-11T06:07:16.930978+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine